The South San Francisco, Calif., biopharmaceutical company in May shut down two trials of zelnecirnon, which was being evaluated as a treatment for asthma and atopic dermatitis.

Removing zelnecirnon means the biotech’s sole remaining clinical-stage asset is tivumecirnon, a phase 2 oncology med being ...

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

While the condition can impact quality of life and mental health, seeking treatment and support can make a powerful ...

Apogee Therapeutics' APG777 shows promise in treating atopic dermatitis with less frequent dosing. See why I rate APGE stock ...

The study compared the risk and cumulative incidence of requiring glaucoma surgery—such as minimally invasive surgery, ...

The field of atopic dermatitis (AD) has been receiving great interest over the last few years with the approvals of both oral ...

Eczema affects millions of Americans, and any number of environmental and health factors can trigger flare-ups. What should ...

Atopic dermatitis can have a significant impact on quality of life in adolescents, so new efficient treatments are needed to ...

ChatGPT recommendations regarding atopic dermatitis (AD) often differ from AAAAI/ACAAI practice parameter recommendations.

Six subjects with a history of atopic dermatitis (AD) were included. To establish the diagnosis, subjects were required to meet two of three modified Hanifin and Rajka criteria: [13] (1 ...

The unique feline dermatological cases veterinary professionals can see at the clinic, plus how to approach them ...